BBGI Public Company Limited
7.00
THB
-0.30
(-4.11%)
ISIN
THA307010R10
Return %
Stock
S&P 500
1Y
136.49
14.20
3Y
75.88
81.12
5Y
- -
68.34
Capital Structure
THB
•
in mil. unless spec.Working Capital
THB
•
in mil. unless spec.Growth Rates
THB
•
in mil. unless spec.Quarterly Revenue
THB
•
in mil. unless spec.Quarterly Earnings Per Share
THB
•
in mil. unless spec.Quarterly Dividends Per Share
THB
•
in mil. unless spec.Company Description
- CEO
- Daechapon Lersuwanaroj
- Full Time Employees
- 513
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- 2098 M Tower Building Bangkok BM Thailand 10260
- IPO Date
- Mar 17, 2022
- Website
- bbgigroup.com
- Similar Companies
- Business
- BBGI Public Company Limited operates as a holding company focused on the biofuel industry and high-value bio-based products in Thailand. The company manufactures and distributes biodiesel products, including methyl ester and crude glycerine; bioethanol products derived from molasses, sugarcane juice, and cassava; and high-value bio-based products such as food supplements like ASTA-IMMU astaxanthin antioxidants under the B Nature+ brand, pharmaceutical-grade hand sanitizers, natural sweeteners like neotame, and enzymatic bio-based products for pesticide residue removal, alongside advanced biotechnology offerings through contract development and manufacturing organization (CDMO) services. It conducts operations through three main segments—Biodiesel, Ethanol, and Others—primarily in Thailand with production facilities in locations including Ayutthaya, Kanchanaburi, Chachoengsao, and Khon Kaen, achieving a group production capacity exceeding 2 million liters per day across ethanol and biodiesel; the company also pursues renewable energy initiatives like biomass, solar, and digester gas, alongside sustainable aviation fuel (SAF) development. Founded in 2018 and headquartered at 2098 M Tower Building, Sukhumvit Road, Bangkok, BBGI listed on the Stock Exchange of Thailand in March 2022 and holds majority or full ownership in key subsidiaries such as BBGI Bioethanol Public Company Limited (formerly KSL Green Innovation), BBGI Biodiesel Company Limited, BBGI Bioethanol (Chachoengsao) Company Limited, BBGI Utility and Power Company Limited, Win Ingredients Company Limited, and joint ventures including BSGF Company Limited for SAF, Biome Company Limited for synthetic biology products, BBGI Fermbox Bio Company Limited for CDMO, and recent collaborations. Recent developments include the acquisition of BBGI-BI to expand biodiesel capacity to 1 million liters per day and advance SAF initiatives targeting commercial operations in Q2 2025; a September 2025 partnership with Thailand's Ministry of Agriculture and Advance Biocarbon for microalgae-based SAF and animal feed production; investments in bio-LNG production from plant waste via a joint venture with Kepple and CleanEdge Resource; the opening of a 200,000 liters per day bioethanol plant in Khon Kaen in February 2023 boosting total ethanol capacity to 800,000 liters per day; full ownership acquisition of BBGI Bioethanol (Chachoengsao) in May 2023; capital increases in BSGF and joint ventures with Fermbox Bio in 2023; recognition in ESG100 for 2025 and sustained excellent governance ratings; and Q3 2025 net profit surging 335% to 94 million baht amid TRIS Rating's affirmation of "A" credit with stable outlook.